Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-09 Sale |
2023-01-11 8:29 pm |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Operating Officer |
16,634 | $1.111 | $18,481 | 110,082 (Direct) |
View |
| 2022-01-07 Sale |
2022-01-11 8:55 pm |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
9,673 | $6.883 | $66,580 | 64,216 (Direct) |
View |
| 2021-01-22 Sale |
2021-01-25 5:36 pm |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
18,000 | $11.95 | $215,100 | 141,689 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-11 06:19 am |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
6,219 | $6.8889 | $42,842 | 55,189 (Direct) |
View |
| 2020-08-14 Sale |
2020-08-18 8:29 pm |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
2,182 | $4.7096 | $10,276 | 61,408 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-05 Option Award |
2024-06-06 4:05 pm |
N/A 2034-06-04 |
Astria Therapeutics Inc. | ATXS | Cole Hugh M Director |
14,100 | $0 | 14,100 (Direct) |
View |
| 2023-06-02 Option Award |
2023-06-06 08:05 am |
N/A 2033-06-01 |
Astria Therapeutics Inc. | ATXS | Cole Hugh M Director |
14,100 | $0 | 14,100 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-03 8:29 pm |
N/A 2032-08-01 |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Operating Officer |
60,000 | $0 | 166,716 (Direct) |
View |
| 2022-06-09 Option Award(A) |
2022-06-21 08:32 am |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | Cole Hugh M Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-09 5:57 pm |
N/A 2032-06-08 |
Astria Therapeutics Inc. | ATXS | Cole Hugh M Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2022-02-01 Option Award(A) |
2022-03-17 8:50 pm |
N/A 2032-02-01 |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
85,000 | $0 | 85,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:38 pm |
N/A 2032-02-01 |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
127,500 | $0 | 191,716 (Direct) |
View |
| 2021-06-02 Option Award |
2021-06-02 7:14 pm |
N/A 2031-06-01 |
CATABASIS PHARMACEUTICALS INC | CATB | Cole Hugh M Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 5:45 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
26,700 | $0 | 127,289 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 5:45 pm |
N/A 2031-02-01 |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
53,400 | $11.89 | 127,289 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-25 5:36 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
5,000 | $4.4 | 141,689 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-25 5:36 pm |
N/A 2029-02-01 |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
10,000 | $0 | 141,689 (Direct) |
View |
| 2021-01-22 Exercise |
2021-01-25 5:36 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | Cole Hugh M Chief Business Officer |
5,000 | $6.55 | 141,689 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-12 11:56 am |
N/A 2030-06-10 |
CATABASIS PHARMACEUTICALS INC | CATB | Cole Hugh M Director |
7,500 | $0 | 7,500 (Direct) |
View |